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ABSTRACT
Objective Progastrin is the incompletely cleaved
precursor of gastrin that is secreted by G-cells in the
gastric antrum. Both gastrin and progastrin bind to the
CCK2 receptor (Cckbr or CCK2R) expressed on a subset
of gastric epithelial cells. Little is known about how
gastrin peptides and CCK2R regulate gastric stem cells
and carcinogenesis. Interconversion among progenitors
in the intestine is documented, but the mechanisms by
which this occurs are poorly defined.
Design We generated CCK2R-CreERT mice and
performed inducible lineage tracing experiments.
CCK2R+ antral cells and Lgr5+ antral stem cells were
cultured in a three-dimensional in vitro system.
We crossed progastrin-overexpressing mice with
Lgr5-GFP-CreERT mice and examined the role of
progastrin and CCK2R in Lgr5+ stem cells during
MNU-induced carcinogenesis.
Results Through lineage tracing experiments, we found
that CCK2R defines antral stem cells at position +4,
which overlapped with an Lgr5neg or low cell population
but was distinct from typical antral Lgr5high stem cells.
Treatment with progastrin interconverts Lgr5neg or low
CCK2R+ cells into Lgr5high cells, increases CCK2R+ cell
numbers and promotes gland fission and carcinogenesis
in response to the chemical carcinogen MNU.
Pharmacological inhibition or genetic ablation of CCK2R
attenuated progastrin-dependent stem cell expansion
and carcinogenesis.
Conclusions CCK2R labels +4 antral stem cells that
can be activated and expanded by progastrin, thus
identifying one hormonal trigger for gastric stem cell
interconversion and a potential target for gastric cancer
chemoprevention and therapy.
INTRODUCTION
Gastric cancer is the second leading cause of cancer
mortality worldwide with most patients dying
within 5 years of their diagnosis.1 2 Gastric cancer
has many discrete types that may be classified by
site and/or histology.3 In this study, we focus on
antral stem cells in the distal stomach and also
mouse models of intestinal-type gastric cancer that
predominantly, although not exclusively, arise from
the distal stomach.4–7 The events that initiate
intestinal-type gastric carcinogenesis are poorly
understood.
Lgr5 expression identifies long-lived, self-
renewing stem cells in the gastric antrum.8 These
cells divide actively, lineage trace entire antral
glands within 7–10 days and persist for the lifetime
of the mouse. Activation of Wnt signalling in these
Lgr5+ cells also induces gastric adenoma forma-
tion.8 Sox2, which may overlap with Lgr5, also
labels antral stem cells.8–10 Single Lgr5+ antral
stem cells can be sorted and grown into organoids
or miniguts, although requiring a number of
growth factors, including Wnt3A, EGF, Noggin
Significance of this study
What is already known on this subject?
▸ The gastrin family of peptides has been
reported to play an important role in gastric
homeostasis and carcinogenesis.
▸ The CCK2R is highly expressed in the proximal
stomach, primarily in parietal cells and
enterochromaffin-like (ECL) cells, although the
expression of CCK2R in the gastric antrum is
less clear.
▸ Lgr5+ cells at the base of antral glands label
long-lived, self-renewing stem cells; however,
the heterogeneity of antral stem cells and their
regulation has not been investigated.
What are the new findings?
▸ CCK2R marks Lgr5neg or low antral stem cells
located at position +4, slightly above typical
Lgr5high stem cells.
▸ CCK2R regulates the interconversion of CCK2R
+ cells into Lgr5high cells, and induces clonal
expansion.
▸ CCK2R modulates antral carcinogenesis
following progastrin stimulation.
How might it impact on clinical practice in
the foreseeable future?
▸ These results highlight a novel mechanism for
hormonal regulation of gastric stem cell
interconversion.
▸ We identify CCK2R as a potential target for
gastric cancer chemoprevention and therapy.
Stomach
544 Hayakawa Y, et al. Gut 2015;64:544–553. doi:10.1136/gutjnl-2014-307190
group.bmj.com on May 3, 2017 - Published by http://gut.bmj.com/Downloaded from 
and R-spondin1.8 11 In this culture system, gastrin reportedly
promotes the growth of gastric stem cells.8 12 13 However, the
precise effects of gastrin peptides and their receptor Cckbr
(CCK2R) signalling on antral stem cells both in vivo and in
vitro have not been investigated.
Gastrin mediates its effects on the proximal and distal
stomach through binding to the CCK2R, a seven-
transmembrane, G protein-coupled receptor.14 The CCK2R is
highly expressed in the proximal stomach, primarily in parietal
cells and enterochromaffin-like (ECL) cells in the oxyntic
mucosa, where its role in acid secretion is well described,
although it is also expressed in neck progenitors in the prolifera-
tive zone.15 While the expression of CCK2R in the gastric
corpus has been well characterised,16 17 its expression pattern in
the distal stomach is less clear. Previous reports have shown that
CCK2R knockout (CCK2R−/−) resulted in reduced parietal,
ECL and somatostatin-producing enteroendocrine cells in the
stomach, but a compensatory increase in the gastrin-producing
G-cells in the antrum.18 19 However, in health, CCK2R−/−
mice, as well as hypergastrinemic (INS-GAS) or gastrin knock-
out (GAS-KO) mice, do not show proliferative or dramatic
histological changes in the antrum.20 21 Thus, the overall role of
CCK2R signalling in antral homeostasis has not been clarified.
In addition to the well-known amidated gastrins, gastrin exists
in a number of molecular forms, including the longer precursor
form, progastrin, an 80-amino acid peptide.22 Progastrin and
other incompletely processed forms of gastrin typically com-
prise less than 10% of the total secreted peptide, but when pro-
cessing is impaired, elevations in these non-amidated forms can
occur. We have reported that human progastrin-overexpressing
(hGAS) transgenic mice show increased colonic proliferation
and enhanced tumour development, indicating a role for pro-
gastrin as a trophic growth factor for the colonic epithelium,23 24
largely through binding to the CCK2R leading to expansion of
progenitors.25 26 Although progastrin binds to the identical
receptor (CCK2R) as amidated gastrin, the signalling pathways
are quite different,26 accounting for the fact that progastrin sti-
mulates colonic proliferation while amidated gastrin does not.
Nevertheless, while the CCK2R is expressed at much higher
levels in the gastric epithelium than in the colon, the role of
progastrin on the stomach has not been elucidated.
In the current study, we used CCK2R-CreERT mice in order
to clarify the location and function of CCK2R in the antrum.
We found that CCK2R+ cells with low or negative expression
of Lgr5 (Lgr5neg or low) contain long-lived antral stem cells, and
progastrin, but not amidated gastrin, stimulates these cell
lineages in vivo and in vitro through CCK2R. Activation of
CCK2R enhances antral gland fission and carcinogenesis
through an expansion of antral stem cells. Targeting CCK2R sig-
nificantly suppressed antral carcinogenesis in vivo. These results
confirm that CCK2R signalling plays an important role in
gastric carcinogenesis by regulating stem cell function and epi-
thelial homeostasis.
MATERIALS AND METHODS
Mice and gastric cancer models
The animal protocol was reviewed and approved by the
Columbia University Medical Center Institutional Animal Care
and Use Committee (IACUC), and all mice were bred under
specific pathogen free (SPF) conditions. INS-GAS mice27 and
hGAS mice23 were backcrossed to C57BL6 background.
Lgr5-GFP-IRES-CreER knockin mice28 (Lgr5-GFP mice) were
provided by Dr Hans Clevers, and mated with hGAS mice and
B6.129S4-Gt(ROSA)26Sortm1Sor5/J, referred to as R26rLacZ
mice ( Jackson Laboratories). CCK2R−/− mice were purchased
from Jackson Laboratories. CCK2R-GFP BAC transgenic mice
were purchased from MMRRC (GENSAT project29). For gener-
ation of CCK2R-BAC-CreERT mice, BAC recombination was
carried out as described at http://web.ncifcrf.gov/research/brb/
recombineeringInformation.aspx using the CreTM-FrtNeoFrt
cassette as described previously.30 For lineage tracing experiments,
mice were administered 1–6 mg tamoxifen in 200 μL corn oil con-
taining 5–30 mg/mL tamoxifen by oral gavage. The CCK2R antag-
onist YF476 was a kind gift of Dr Keiji Miyata and Dr Hidenobu
Yuki (Astellas Pharma, Tokyo, Japan). The drug was dissolved in
PEG 300 at the concentration of 12 mg/mL and intraperitoneally
injected twice per week at the dose of 40 mg/kg.31
In vitro culture system
Crypt and single-cell isolation and cultures were performed as
described previously8 with minor modifications. Two or three
mice were used for each experiment, and all results were con-
firmed by at least two independent experiments.
Detailed information is described in online supplementary
methods.
RESULTS
CCK2R marks long-lived gastric stem cells in the antrum
To analyse the localisation of CCK2R expression within the
stomach, we generated CCK2R-CreERT-BAC transgenic mice,
crossed them to reporter mice and induced recombination (see
online supplementary figure S1A). Twenty-four hours after tam-
oxifen induction, reporter gene expression was observed in
CCK2R+ H/K-ATPase+ parietal cells and chromogranin A+
(ChgA+) ECL cells in the corpus (see online supplementary
figure S1, B, C). Gastric intrinsic factor+ (GIF+) chief cells
were not recombined (see online supplementary figure S1D).
Thus, this BAC-transgenic line fairly reflected the known distri-
bution of CCK2R. Interestingly, CCK2R+ recombined cells
were detected most frequently as single cells in the gastric antral
epithelium at a position just above the Lgr5+ cells at the base of
the gland (figure 1A).8 These CCK2R+ cells were confirmed as
epithelial cell types by E-cadherin and 3,3’-diaminobenzidine
(DAB) staining (figure 1A). The majority of these antral
CCK2R+ cells were ChgA-negative (9.1% of recombined cells
in the antrum were ChgA+, figure 1B and online
supplementary figure S1I), and also negative for other differen-
tiated markers including TFF1, Dclk1, gastrin and somatostatin
(see online supplementary figure S1E–H). Interestingly, analysis
of a separate CCK2R-GFP transgenic mouse line29 confirmed
the presence of CCK2R+ cells in the antrum near the base and
also established that CCK2R-GFP+ cells were predominantly
ChgA-negative cells (11.1% of antral GFP+ cells were ChgA+,
figure 1C and see online supplementary figure S1I). Thus, the
vast majority of CCK2R+ cells in the antrum were undifferenti-
ated. The expression of CCK2R in the gastric antrum was
also validated by immunofluorescence (figure 1D). In
CCK2R-CreERT mice, the recombined cells expanded rapidly
to trace whole antral glands within 10 days after tamoxifen
induction and the traced glands persisted beyond 12 months
(figure 1E, F). Although we observed occasional apoptosis in
the corpus after giving 6 mg tamoxifen, we did not find any
such histological changes or apoptotic cells in the antrum (see
online supplementary figure S1J, K). Furthermore, lineage
tracing from CCK2R+ cells occurred with 1 mg tamoxifen
administration (see online supplementary figure S1L), suggesting
that CCK2R+ lineage tracing in the antrum is independent of
the tamoxifen dose. The CCK2R+ cell progeny differentiated
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into all mature antral cell types, including G-cells (gastrin+), pit
cells (TFF1+), tuft cells (Dclk1+) and D-cells (somatostatin+)
(figure 1G).
Next, we performed in vitro culture of CCK2R+ antral cells.
Recombined CCK2R+ cells were sorted 1 day after tamoxifen
induction by fluorescence-activated cell sorting (FACS) and
placed in our three-dimensional culture system (figure 1H).8
Approximately 0.8±0.23% antral epithelial cells were labelled
by CCK2R, and these CCK2R+ cells robustly formed gastric
organoids in culture (colony formation efficiency 2.1±0.56
(average±SE) %), which could be maintained for more than
2 months with the growth of budding events (figure 1I). In con-
trast, CCK2R-negative antral cells were relatively inefficient at
organoid formation in vitro (colony formation efficiency 0.2
±0.36%, p=0.004 compared with CCK2R+ cells, figure 1J).
These data suggest that CCK2R marks long-lived antral stem
cells in vivo and in vitro.
Actively cycling CCK2R+ stem cells are higher up in the
antral gland than Lgr5+ stem cells
Next, we investigated the characteristics of CCK2R+ stem cells
in comparison to Lgr5+ stem cells in the antrum. As reported
previously,8 Lgr5+ cells were located at the base of antral
glands in Lgr5-GFP-CreERT mice, predominantly below pos-
ition +4 (figure 2A, B). In contrast, analysis of CCK2R-CreERT
mice crossed to reporter mice showed that at day 1 following
tamoxifen, CCK2R+ cells were quite rare (average 1–2 cells
/gland) and were distributed in the lower half of glands from
position +1 to +13, with the peak at position +4 (figure 2B)
and the vast majority between +3 and +7, indicating that most
CCK2R+ stem cells reside above the basally located Lgr5+
cells. Lgr5+ cells in the antrum are reported to be actively
cycling.8 We found that approximately 10% of Lgr5+ cells are
Ki67+ (figure 2C, D), although the proliferation rate appears
slightly lower than that previously reported.8 In contrast,
approximately 30% of CCK2R+ antral cells were Ki67+
(figure 2C, D), suggesting that CCK2R+ cells are in general
more rapidly cycling than Lgr5+ cells. Double staining of ChgA
and Ki67 revealed that there were no proliferating cells among
the ChgA+ cells, indicating that the CCK2R+ stem cells likely
reside among the ChgA-negative population (see online supple-
mentary figure S2A). Thus, these data demonstrate that
CCK2R+ cells and Lgr5+ cells are distinct stem cells in the
gastric antrum. Indeed, immunofluorescence of CCK2R in
Lgr5-GFP mice confirmed that CCK2R are predominantly
expressed in GFP-negative cells (figure 2E).
CCK2R is expressed in Lgr5neg or low cells, which could
convert to Lgr5high cells in response to progastrin
We have previously reported that progastrin binds to and acti-
vates CCK2R, leading to the expansion of CCK2R-expressing
cells.25 32 To test the effects of progastrin on antral stem cells
Figure 1 CCK2R marks long-lived gastric stem cells in the antrum. (A) CCK2R-BAC-CreERT2;Rosa26rTdTomato mice were given 6 mg tamoxifen
and sacrificed after 24 h. Recombined red cells (allows) are observed at near the gland base. Middle panel was stained by E-cadherin antibody.
Right panel is GFP staining of CCK2R-BAC-CreERT2;Rosa26mTmG mouse antrum. (B) Immunostaining of ChgA (green) with CCK2RCreERT/TdTomato
mice antrum 24 h after tamoxifen. (C) Immunostaining of ChgA (red) with CCK2R-GFP (green) transgenic mice antrum. (D) Immunofluorescence of
CCK2R (red) in mouse antrum. (E) Representative lineage-tracing pictures after 5 days, 10 days, 6 months and 12 months. (F) Ratio of the number of
lineage-traced glands per total glands at day 10, 6 months and 12 months. (G) Double staining of gastrin, TFF1, somatostatin and Dclk1 (green)
with CCK2RCreERT/TdTomato mice 6 months after tamoxifen. (H, I) Single-cell sorting (H) and time course (days 1, 3, 7 and 60) of CCK2R+ red
single-cell culture (I) isolated 24 h after tamoxifen induction. ( J) The percentage of single-cell colony formation of CCK2R+ and CCK2R- cells. Data
are plotted as the means±SE (*p<0.05).
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in vivo, we generated Lgr5-GFP;hGAS mice and analysed
CCK2R expression. Interestingly, in the Lgr5-GFP;hGAS double
transgenic mice, the expression of CCK2R in the Lgr5-GFP+
population is markedly increased (figure 3A, B), suggesting the
possibility of interconversion of Lgr5neg or lowCCK2R+ cells to
Lgr5-high expressing (Lgr5high) cells in response to progastrin. In
contrast, ChgA+ endocrine cells did not become Lgr5-positive
even with progastrin overexpression (see online supplementary
figure S2B), indicating that progastrin does not activate in this
manner the ChgA+ cell population, but instead interconverts
undifferentiated CCK2R+ stem cells. We observed by immuno-
fluorescence that each normal antral glands only contained one or
two of CCK2R+ cells, but progastrin overexpression expanded
the CCK2R+ population (figure 3C). However, the Ki67+ prolif-
eration index in CCK2R+ cells was almost identical in wild-type
(WT) and hGAS mice mated with CCK2RCreERT mice (see
online supplementary figure S2C, D), suggesting that progastrin-
dependent activation of CCK2R leads to increased CCK2R+Lgr5+
cells (figure 3A) through interconversion or symmetric cell division
rather than simply enhancing proliferation.
When antral glands were cultured with standard growth
factors, including Wnt3A, R-spondin1, EGF and Noggin, treat-
ment with progastrin did not affect organoid numbers (data not
shown). Since progastrin induces expansion of colonic progeni-
tors through downregulation of bone morphogenetic protein
(BMP) 2 expression,32 we reasoned that removal of Noggin (a
BMP antagonist) from the culture media might enhance
progastrin-mediated effects. We observed that progastrin treat-
ment increased organoid number following the first passage in
Noggin-free conditions compared with the vehicle-treated group
(figure 3D). Abrogating the effects of progastrin by either
YF476, a CCK2R antagonist, or genetic knockout of CCK2R
(CCK2R−/−), abolished these changes (figure 3D). However, the
size of the organoids was not affected by progastrin or YF476,
suggesting less of an effect on proliferation and more of an
effect on stem cell self-renewal (figure 3E). Gene expression of
CCK2R was significantly upregulated by progastrin treatment
(figure 3F), which supports the in vivo CCK2R+ cell expansion
in hGAS mice (figure 3C).
We then sorted single gastric epithelial cells from the antral
crypts of Lgr5-GFP mice and analysed both Lgr5low cells and
Lgr5high cells separately (figure 3G). When we cultured sorted
single Lgr5high cells with standard culture medium, the colony
formation efficiency was 5%, while Lgr5low cells had a much
lower efficiency (about 0.3%, p=0.01, compared with Lgr5high,
figure 3H, I), consistent with previous reports.8 11 33 Amidated
gastrin treatment did not significantly enhance colony formation
in either Lgr5high or Lgr5low cell populations (figure 3I). In con-
trast, progastrin significantly increased colony formation, but
only in Lgr5low cells (some of which express CCK2R), while
there was no effect of progastrin in Lgr5high cells (mostly
CCK2R-negative) (figure 3I). Quantitative RT-PCR indicated
that Lgr5 expression was significantly upregulated in cultured
Lgr5low populations by progastrin treatment, and this upregula-
tion and colony formation were inhibited by YF476 (figure 3J
and see online supplementary figure S2E). Furthermore,
CCK2R gene expression in Lgr5high cells was markedly
increased in sorted cells from Lgr5-GFP;hGAS mice compared
with Lgr5-GFP mice, and this increase was blocked by 2-week
YF476 administration (figure 3K). Thus, Lgr5neg or lowCCK2R+
cells respond to progastrin by rapid interconversion into
Lgr5high cells, thus expanding an active antral stem cell pool.
Progastrin increases gastric stem cell number and crypt
fission through CCK2R
To test whether progastrin also promoted interconversion of
Lgr5neg or low to Lgr5high antral stem cells to initiate gastric car-
cinogenesis, we treated Lgr5-GFP mice and Lgr5-GFP;hGAS
mice with N-nitroso-N-methylurea (MNU), an antral carcino-
gen.34 Without MNU treatment, gastric histology, acid secretion
and the number of Lgr5+ cells appeared to be similar between
Lgr5-GFP mice and Lgr5-GFP;hGAS mice at baseline (see online
Figure 2 Actively cycling CCK2R+ stem cells reside at higher position than Lgr5+ stem cells. (A) Representative picture of Lgr5-GFP mouse
antrum. (B) Position of Lgr5-GFP+ cells and CCK2R+ red recombined cells in the antrum 24 h after tamoxifen induction. Total 60 glands from three
mice were counted. (C) Representative images of Ki67 staining (red) in Lgr5-GFP and CCK2RCreERT; Rosa26mTmG mouse. Red arrows indicate
double-positive cells. (D) The percentage of Ki67+ cells in total Lgr5-GFP or CCK2R+ cells. Total 50 glands from three mice were counted
(*p<0.05). (E) Immunofluorescence of CCK2R (red, arrow) in Lgr5-GFP mice antrum.
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supplementary figure S3A–C). The serum progastrin level is con-
sistently high in the hGAS mice during all experiments (see
online supplementary figure S3D). However, 3 months following
treatment with MNU, Lgr5-GFP;hGAS mice showed a greater
increase in the number of GFP+ cells compared with
MNU-treated Lgr5-GFP mice (figure 4A, B). Lgr5 expression
was upregulated in the MNU-treated WT and hGAS mice, par-
ticularly in the hGAS group (figure 4C). At this 3-month time
point, hGAS mice displayed more severe hyperplasia and gland
irregularity compared with WT mice. The expression of Ki67
and CD44 in hGAS mice was also significantly greater than in
WT mice (see online supplementary figure S4A, B). These results
suggest that progastrin overexpression promotes the expansion
of Lgr5+ stem cells following exposure to a gastric carcinogen.
In the setting of carcinogenic exposure, the expansion of
gastrointestinal stem cells leads to crypt fission.35 Recent studies
have shown that progastrin increases crypt fission and symmetric
cell division in the colon.32 We observed that in the
MNU-induced antral cancer model, progastrin also increased
antral gland fission (figure 4D, E). To test the relationship
between antral gland fission and stem cell expansion, we lineage-
traced antral glands following MNU treatment in
Lgr5-GFP-CreERT mice mated with Rosa26rLacZ reporter mice
(figure 4F). Twelve weeks after the start of MNU treatment, we
observed that the number of contiguously labelled glands was
increased by progastrin overexpression, consistent with the
observed increases in antral gland fission (figure 4G, H). Similarly,
in vitro lineage tracing experiments of CCK2R also revealed that
CCK2R-lineage expansion was enhanced by progastrin treatment
compared with the untreated group (see online supplementary
figure S5A, B). Taken together, progastrin expands CCK2R+
stem cells through interconversion and gland fission (figure 4I).
CCK2R inhibition prevents antral crypt fission
Next, we examined the effects of CCK2R gene ablation and
inhibition of CCK2R with small molecule antagonists during
MNU-induced carcinogenesis. After five cycles of MNU treat-
ment, CCK2R−/− mice showed significantly fewer gland fission
Figure 3 CCK2R is expressed in Lgr5low cells, which could convert to Lgr5high cells in response to progastrin. (A) Immunofluorescence of CCK2R
(red, arrow) in Lgr5-GFP;hGAS mice antrum. (B) Average numbers of Lgr5+CCK2R+ double-positive cells in total CCK2R+ cells in Lgr5-GFP mice
(n=3) and Lgr5-GFP;hGAS mice (n=3). Data are plotted as the means±SE (*p<0.05). (C) The numbers of CCK2R+ cells in WT and hGAS mouse
antrum by immunofluorescence. Data are shown as numbers of glands with one, two or three cells in each glands. (D, E) The numbers (D) and sizes
(E) of gastric organoids from WT and CCK2R−/− mice (n=4 well/group) after 14 days (passage 1) in culture in Wnt3A, EGF, R-spondin1. Organoids
were treated with progastrin (1 mg/mL) and/or 1 uM YF476, *p<0.05. (F) GAPDH-normalised gene expression of CCK2R in cultured organoids with
or without progastrin (n=4). Data are plotted as the means±SE (*p<0.05). (G) Fluorescence-activated cell sorting (FACS) plot of digested single cells
from Lgr5-GFP mouse stomach. Boxes indicate Lgr5high, Lgr5low and Lgr5neg groups. (H) Representative time course of Lgr5+ gastric single-cell
culture. (I) Average colony-forming efficiency of Lgr5low and Lgr5high cell culture after 7 days (n=5). Cells were treated with progastrin (1 mg/mL) or
amidated gastrin (G-17, 100nM) as indicated. Data are plotted as the means±SE (*p<0.05). ( J) GAPDH-normalised Lgr5 gene expression in sorted
Lgr5low cells with or without progastrin treatment or YF476 after 5 days. Data are plotted as the means±SE (n=5, *p<0.05). (K) Relative CCK2R
expression in Lgr5high population compared with Lgr5low population in Lgr5-GFP mice and Lgr5-GFP;hGAS mice. Mice were treated with YF476 or
vehicle for 2 weeks prior to sorting. Data are plotted as the means±SE (n=5, *p<0.05).
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events (figure 5A, B). The initiation of CCK2R antagonism by
YF476 at an early stage (from the beginning of MNU treatment)
(see online supplementary figure S6A) also successfully sup-
pressed crypt fission in the antrum in WT and hGAS mice
(figure 5C). Furthermore, YF476 treatment prevented Lgr5+
cell expansion in hGAS mice (figure 5D, E), suggesting that the
CCK2R signal is important for the gland fission and stem cell
expansion following exposure to MNU.
To confirm that the effects of progastrin were
CCK2R-dependent in vivo, we crossed Lgr5-GFP;hGAS mice to
CCK2R−/− mice. The number of Lgr5+ cells was similar
between hGAS;CCK2R−/− mice and hGAS;CCK2R+/− mice
without MNU treatment (see online supplementary figure S7).
After five cycles of MNU treatment, however, CCK2R−/− mice
failed to expand their Lgr5+ stem cell pool to the same extent
(figure 5F, G). Thus, progastrin overexpression expanded Lgr5+
cells in a CCK2R-dependent fashion.
Progastrin promotes antral gastric cancer in mice
Thirty-six weeks after Helicobacter felis inoculation and five
cycles of MNU treatment, WT and hGAS mice developed antral
cancer. The tumour number and tumour size, however, were
significantly increased in hGAS mice compared with WT mice
(figure 6A, B), with hGAS mice also showing more advanced
grade tumours along with increased Lgr5 expression (figure 6C).
In the H. felis gastric cancer model (without MNU), infected
hGAS mice at 18 months exhibited polypoid lesions at the gastric
pylorus (see online supplementary figure S8A), a phenotype not
typically observed in H. felis-infected WT mice.36 Histologically,
H. felis-infected hGAS mice had moderate-to-severe hyperplasia
with dysplastic changes in the gastric antropyloric region, while
H. felis-infected WT mice showed minimal changes in the corre-
sponding distal stomach (see online supplementary figure S8B).
Accordingly, immunohistochemistry of Ki67 and CD44 revealed
that progastrin overexpression enhanced cell proliferation and
dysplastic changes in the antrum (see online supplementary
figure S8C, D). Moreover, when we treated MNU-treated mice
with YF476 at a later stage (starting at 30 weeks) (see online sup-
plementary figure S6B), we observed a significant decrease in
tumour number and tumour size in hGAS mice (figure 6D–F),
but not in WT mice (data not shown). These data suggest that
progastrin/CCK2R axis, and following stem cell expansion with
gland fission, contribute to antral tumour initiation and
progression.
Figure 4 Progastrin increased gastric stem cell number and crypt fission through CCK2R. (A) GFP staining of Lgr5-GFP and Lgr5-GFP;hGAS mice
3 months after MNU treatment. (B) The numbers of GFP+ cells in Lgr5-GFP and Lgr5-GFP;hGAS mice with or without MNU. Cells were counted at
20 different glands in the each group mice (n=3). All values were expressed as mean±SE (*p<0.05). (C) GAPDH-normalised expression of the Lgr5
gene in the stomachs of WT and hGAS with or without MNU treatment (n=3 for each group). Relative expression in untreated WT mice is
represented as 1.0. Data are plotted as the means±SE (*p<0.05). (D) Representative crypt fission picture (arrow). (E) The numbers of crypt fission
per total glands in WT and hGAS mice (three mice for each group, and three sections per mouse were counted) after MNU treatment. Data are
plotted as the means±SE (*p<0.05). (F) Protocol of tamoxifen induction and MNU treatment. (G) Representative sections of β-gal+ labelled antral
crypts in Lgr5-CreER;R26rLacZ and Lgr5-CreER;hGAS;R26rLacZ mice exposed to five cycles of MNU. (H) Average ratio of β-gal+ labelled contiguous
labelled glands to total β-gal+ labelled antral crypts. Each group has three mice and 20 labelled crypts per mouse were measured. Data are plotted
as the means±SE (*p<0.05). (I) Models of the role of progastrin in the antrum during carcinogenesis.
Stomach
Hayakawa Y, et al. Gut 2015;64:544–553. doi:10.1136/gutjnl-2014-307190 549
group.bmj.com on May 3, 2017 - Published by http://gut.bmj.com/Downloaded from 
DISCUSSION
We investigated the role of CCK2R signalling in antral homeosta-
sis and carcinogenesis. Using inducible Cre-dependent lineage
tracing, we established that CCK2R is expressed in Lgr5neg or low
cells located above Lgr5high cells, at position +4 in the antral
gland. These CCK2R+ cells are antral stem cells that can lineage
trace Lgr5+ antral stem cells and all mature antral lineages, with
recombination persisting more than 12 months following adult
induction. Progastrin accelerated antral carcinogenesis through
an expansion of antral gastric stem cells as a result of progastrin-
mediated interconversion of CCK2R+Lgr5neg or low stem cells
into Lgr5high cells. In turn this increased crypt fission and predis-
posed to antral carcinogenesis. These effects were blocked by
inhibition of CCK2R signalling either by YF476 or genetic
knockout of CCK2R.
Given that Lgr5+ cells are a well-validated antral stem cell
population, we examined possible overlap of CCK2R with Lgr5.
We found that CCK2R was primarily expressed in Lgr5neg or low
cells at peak position +4, rather than in Lgr5high cells located at
the base. Gastrointestinal stem cells are thought to be heteroge-
neous.37 In the small intestine, Potten et al suggested that the
intestinal +4 label retaining stem cells by nucleotide labelling
assay.38 Lgr5+ cells at the base of glands were later identified as
rapidly cycling stem cells,39 while the relatively quiescent stem
cells at position +4 have been fate mapped using the expression
of Bmi1, Hopx and mTERT.40–42 In the gastric antrum, it has
been suggested that the anatomical narrowing at the lower third
of the gland, known as the isthmus, is the site of cellular renewal,
and that immature cells migrate and differentiate bidirectionally
from this point.43–45 Proliferation rate of antral isthmal cells are
reported to be approximately 37%,44 which seems equivalent to
antral CCK2R+ cell population (30%). The distribution and
lineage tracing that we described confirms, for the first time, that
CCK2R+ marks this isthmus (or +4) stem cell in the gastric
antrum. The CCK2R+ cell population in the gastric antrum may
also be heterogeneous, but includes a bona fide actively prolifer-
ating stem cell population that does not overlap with Sox2 cells
(see online supplementary figure S9). Although TFF2+ cells also
exist at the base of antral glands, our previous report showed that
no lineage tracing was observed in the antrum.30 Thus, CCK2R
+ antral stem cells do not express TFF2. The presence of rare
CCK2R+ antral stem cells at the +4 position, along with mul-
tiple Lgr5+ cells at the antral base, raises questions about
whether there is an antral stem cell hierarchy. Previous radioauto-
graphic and electron microscopic analysis revealed that the antral
isthmal cells contain five different cell types that can be labelled
Figure 5 CCK2R inhibition prevents antral crypt fission. (A) H&E staining of five-cycle MNU-treated antrum of WT and CCK2R−/− mice. (B) The
numbers of crypt fission per total glands in WT and CCK2R mice (n=3, each group) after MNU treatment. Data are plotted as the means±SE
(*p<0.05). (C–E) The numbers of crypt fission per total glands (C) and Lgr5+ cell number (E) in Lgr5-GFP and Lgr5-GFP;hGAS mice (n=3, each
group) treated with YF476 or vehicle during MNU treatment. Representative Lgr5-GFP pictures of Lgr5-GFP;hGAS mice with or without progastrin
are shown in (D). Data are plotted as the means±SE (*p<0.05). (F) H&E staining (top) and GFP expression (bottom) in MNU-treated Lgr5-GFP;hGAS;
CCK2R+/− mice and Lgr5-GFP;hGAS;CCK2R−/− mice (n=4, each group). (G) Quantification of crypt fission and GFP+ cell number. Data are plotted as
the means±SE (*p<0.05).
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by 3H-thymidine in 1 h.44 45 Further work is needed to identify
other isthmal stem/progenitor cell markers and define relation-
ships among these multiple stem cell populations.
Previous reports suggest that intestinal +4 stem cells and
Lgr5+ crypt base columnar cells (CBCs) may be able to dynam-
ically interconvert especially in response to acute epithelial
injury,41 46 47 although it is unclear how this interconversion is
regulated. We observed that progastrin increased CCK2R/Lgr5
double-positive cell numbers in mice and expanded Lgr5+ cells
after MNU treatment. Also, our single-cell cultures showed that
progastrin enhanced both colony formation efficiency and Lgr5
expression in CCK2R+ cells. Thus, we conclude that progastrin
promotes expansion and renewal of CCK2R+ stem cells by con-
verting CCK2R+Lgr5neg or low cells into Lgr5high stem cells.
Although the colony-forming efficiency of CCK2R+ cells are
lower than Lgr5+ cells (2% vs 5% in our data), the highly
Wnt-dependent culture condition seems to be optimised for Lgr5
+ or Wnt-responsive cell types. The culture method is likely to
be critical for specific stem cell propagation in vitro, and as
would be expected from our in vivo findings, different stem cells
are best supported by unique conditions and microenvironments.
The very premise of which underpins the entire concept of stem
cell interconversion. We have recently shown that CCK2R signal-
ling downregulated BMP2 expression, which may also contribute
to interconversion.32 Hormone-mediated stem cell interconver-
sion may be a common mechanism by which trophic hormones
expand stem cells in development and repair.
We have reported that progastrin promotes colonic cell prolif-
eration and cell division through CCK2R in vivo and in
vitro.25 32 48 Given that CCK2R is expressed at higher levels in
the stomach,25 where a physiological role is well established,
and that progastrin is overexpressed in some gastric cancers,49
antagonising progastrin signalling could theoretically be effect-
ive as therapy in some distal gastric cancers. Nevertheless, we
have also shown that amidated gastrin, the most abundant form
of gastrin that signals through CCK2R, inhibits antral gastric
cancer.50 Thus, progastrin and amidated gastrin induce opposite
effects in the distal stomach, possibly through ligand competi-
tion, with each serving as a partial antagonist for the other. The
opposite effects of amidated gastrin and progastrin on the distal
stomach suggest important signalling differences between these
two gastrin isoforms. We did not find any promoting effect of
amidated gastrin on colony formation ability in Lgr5+ cells.
The effect of amidated gastrin in gastric stem cell regulation
needs to be further clarified.
The CCK2R antagonist YF476 reduced crypt fission and
tumourigenesis in hGAS mice, suggesting that YF476 blocks
progastrin-mediated cancer promoting effects. While
YF476-treated WT mice treated early showed decreased crypt
fission, mice that were only treated at a later stage failed to
show any tumour regression. Consistently, CCK2R−/− mice also
had reduced crypt fission at the beginning but ultimately devel-
oped comparable tumour burden (data not shown). Thus,
CCK2R inhibition would only likely to be therapeutically useful
Figure 6 Progastrin promotes antral carcinogenesis in mice. (A–C) WT and hGAS mice with Lgr5-GFP were treated with MNU and H. felis, and
sacrificed at 36 weeks after the beginning of MNU (n=10). Macroscopic images (A), dot plots of tumour number and max tumour size (B), H&E
staining (C, top) and Lgr5-GFP expression (C, bottom) are shown. Arrows indicates tumour area (*p<0.05). (D–F) Macroscopic images (D), H&E
staining (E) and dot plots of tumour numbers and sizes (F) of YF476-treated or vehicle-treated hGAS mouse stomachs are shown (n=5, each group).
*p<0.05.
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for a subset of patients with distal gastric cancer, particularly in
those with an increased progastrin to gastrin ratio. The balance
of these hormones may influence an individual’s susceptibility
to gastric cancer as well as the effectiveness of any
CCK2R-directed therapy.
In summary, these data reveal that CCK2R marks a new stem
cell population in the gastric antrum position +4, and that pro-
gastrin, but not amidated gastrin, is a critical modulator of
antral stem cell states. These findings have implications for hor-
monal regulation of other stem cell niches and highlight a novel
stem cell target that may have therapeutic potential in patients
with, or at risk of, antral cancer.
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